Amway (Malaysia) Holdings Berhad operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Amway (Malaysia) Holdings Berhad with three other
drug stores in Asia:
Hemas Holdings Plc
of SRI LANKA
sales of 61.63 billion Sri Lanka Rupees [US$311.24 million]
of which 51%
was Health Care),
PKU HealthCare Corp Ltd
(1.96 billion Chinese Renmimbi [US$306.66 million]
Sinco Pharmaceuticals Holdings Ltd
based in HONG KONG
(2.31 billion Hong Kong Dollars [US$297.48 million]
of which 92%
was Human Albumin Solution).
During the first
quarter of 2021, sales at Amway (Malaysia) Holdings Berhad totalled
353.65 million Malaysian Ringgits.
an increase of 50.7%
from the 234.64 million Malaysian Ringgits in sales at the company during the first quarter of 2020.
This was the largest same quarter increase in sales since the first
quarter of 2015.
Amway (Malaysia) Holdings Berhad reported sales of 1.15 billion Malaysian Ringgits (US$280.18 million)
December of 2020.
increase of 19.4%
versus 2019, when the company's sales were 966.33 million Malaysian Ringgits.